Atlas Trials

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Clinical trial NCT07392255 · RECRUITING

Trial details

NCT number
NCT07392255
Sponsor
Complement Therapeutics
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Geographic Atrophy Secondary to Age-related Macular Degeneration
Start date
2025-12-30
Primary completion
2028-05-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.